NHS National Pharmaceuticals Dasatinib and Paliperidone Injection

Tender description

Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694<br/><br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW 01/05/2023 – 30/04/2024 – (12 Months) <br/>LSNE 01/05/2023 – 30/04/2024 – (12 Months)<br/>NWLN 01/05/2023 – 30/04/2024 – (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE 01/05/2023 – 31/05/2024 (13 Months) <br/>NWLN 01/05/2023 – 31/01/2025 (21 months) Lot 1: 4. Lot 1 CM/PHG/22/5694/00 Supplier offer confirmation (check box) Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. <br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW - 01/05/2023 – 30/04/2024 – (12 Months) <br/>LSNE - 01/05/2023 – 30/04/2024 – (12 Months)<br/>NWLN - 01/05/2023 – 30/04/2024 – (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE - 01/05/2023 – 31/05/2024 (13 Months) <br/>NWLN - 01/05/2023 – 31/01/2025 (21 months) Lot 2: 5. Lot 2 CM/PHG/22/5694/01 Supplier offer confirmation (check box) Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/22/5694/00 - Dasatinib<br/>CESW - 01/05/2023 – 30/04/2024 – (12 Months)<br/>LSNE - 01/05/2023 – 30/04/2024 – (12 Months)<br/>NWLN - 01/05/2023 – 30/04/2024 – (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection:<br/>LSNE - 01/05/2023 – 31/05/2024 (13 Months)<br/>NWLN - 01/05/2023 – 31/01/2025 (21 months)